Denali Therapeutics
DNLI
#4157
Rank
$2.73 B
Marketcap
$17.53
Share price
-2.56%
Change (1 day)
-23.91%
Change (1 year)

Market capitalization of Denali Therapeutics (DNLI)

Market cap: $2.73 Billion USD

As of January 2026 Denali Therapeutics has a market cap of $2.73 Billion USD. This makes Denali Therapeutics the world's 4157th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Denali Therapeutics from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026$2.73 B3.91%
2025$2.63 B-11.19%
2024$2.96 B0.02%
2023$2.96 B-21.48%
2022$3.77 B-30.66%
2021$5.44 B-45.77%
2020$10.04 B499.44%
2019$1.67 B-14.32%
2018$1.95 B42.13%
2017$1.37 B

End of Day market cap according to different sources

On Jan 20th, 2026 the market cap of Denali Therapeutics was reported to be:

$2.73 Billion USD
by Nasdaq info icon info icon
$2.73 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novocure
NVCR
$1.45 B-46.76% Jersey
Novavax
NVAX
$1.33 B-51.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
$3.67 M-99.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
$0.38 B-86.11%๐Ÿ‡ฌ๐Ÿ‡ง UK